Adverse Cardiovascular Events During Painless Gastroscopy Diagnosis and Treatment in Elderly Frail Patients
frail
Clinical Study About Impacts of Anesthesia Methods on Adverse Cardiovascular Events During Painless Gastroscopy Diagnosis and Treatment in Elderly Frail Patients
1 other identifier
interventional
226
1 country
1
Brief Summary
This study aims to compare the effects of conscious sedation and intravenous general anesthesia on cardiovascular events in frail patients undergoing digestive endoscopy diagnosis and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 12, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2026
CompletedFebruary 12, 2026
November 1, 2025
2.1 years
November 27, 2023
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adverse cardiovascular events
The occurrence rate of heart rate abnormal events (defined as heart rate abnormal events with a baseline fluctuation of ± 30%);The incidence of blood pressure fluctuation events (defined as blood pressure fluctuation events with a baseline blood pressure fluctuation of ± 30%);The incidence of angina, myocardial infarction, cardiac arrest, acute heart
during the examination and recovery room time(up to 2 hours)
Secondary Outcomes (3)
The incidence of other adverse events
during the examination and recovery room time(up to 2 hours)
VAS score
during the examination and recovery room time(up to 2 hours)
Satisfaction score
during the examination and recovery room time(up to 2 hours)
Study Arms (2)
The conscious sedation group
EXPERIMENTALconscious sedation
Intravenous general anesthesia group
ACTIVE COMPARATORIntravenous general anesthesia
Interventions
Intravenous general anesthesia group (Group B): sufentanil 0.05-0.1 μ G/kg, administration time 30 seconds, 1mg/kg of propofol administered 2 minutes before examination. Depending on the patient's sleep status, 10mg of propofol can be administered every 30 seconds; Evaluate the patient's MOAA/S score. At 0-1 points, a digestive endoscope is inserted. If there is coughing or physical activity during the examination that the patient cannot tolerate, propofol 10-20mg can be administered multiple times. Evaluate the MOAA/S score again, and continue the operation after 0-1 points.
The conscious sedation group (Group A) received sufentanil 0.05-0.1 5 minutes before examination μ G/kg, administration time 30 seconds, 1-2 mg of midazolam administered 2 minutes before examination; Evaluate the patient's MOAA/S score, insert a digestive endoscope at 2-3 minutes, and add 1-2mg of midazolam if the patient is unable to tolerate coughing or movement during the examination. Reevaluate the MOAA/S score, and continue the operation after 2-3 minutes;
Eligibility Criteria
You may qualify if:
- Age greater than 65 years old, regardless of gender
- ASA is classified as Class II and III;
- BMI 18-28 kg/m2;
- Patients undergoing examination or treatment outside the operating room;
- FRAIL scale score ≥ 3 points 6 The patient voluntarily participated in this study and signed an informed consent form.
You may not qualify if:
- Those who are allergic or contraindicated to drugs such as benzodiazepines, opioids, propofol, and their drug components;
- \. Acute heart failure; Unstable angina pectoris; Myocardial infarction occurred within 6 months prior to screening; Resting electrocardiogram heart rate\<50 beats/minute; Third degree atrioventricular transmission delay; Severe arrhythmia; Moderate to severe heart valve disease;
- \. Patients with severe respiratory diseases (acute respiratory infections, acute exacerbations of chronic obstructive pulmonary disease, uncontrolled asthma, etc.);
- \. Patients who have not received formal antihypertensive treatment or have poor blood pressure control;
- \. Patients with traumatic brain injury, possible presence of intracranial hypertension, cerebral aneurysms, history of cerebrovascular accidents, and central nervous system diseases;
- \. Individuals with mental system diseases (schizophrenia, mania, bipolar disorder, mental disorder, etc.), long-term history of taking psychotropic drugs, and cognitive impairment;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 100050, China
Related Publications (1)
Liu X, Hou H. Impact of anesthesia methods on adverse cardiovascular events during painless gastroscopy in frail older patients: study protocol for a prospective controlled trial. Front Med (Lausanne). 2026 Mar 5;13:1784922. doi: 10.3389/fmed.2026.1784922. eCollection 2026.
PMID: 41868202DERIVED
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- On the premise of ensuring clinical work and safety, in order to objectively evaluate the research results, the single blind method is reasonably used in this project. Patients are unaware of the anesthesia plan, and preoperative data collection and implementation of the anesthesia plan are carried out by experienced anesthesiologists who have undergone detailed training. Postoperative PACU clinical data and postoperative follow-up were followed up by another anesthesiologist who was unaware of the trial group over the phone.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2023
First Posted
January 5, 2024
Study Start
January 1, 2024
Primary Completion
February 12, 2026
Study Completion
February 12, 2026
Last Updated
February 12, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share